Our Technology
Our drug discovery platform is based on our Universal Purinome Capture Platform (UPCP) drug discovery method which identifies highly selective kinase inhibitors.
How It Works
The Universal Purinome Capture Platform (UPCP) platform allows for discovery of intrinsically selective chemical scaffolds towards human kinases for further medicinal chemistry development. Human kinome screening of selectivity further validates the selective nature of our kinase inhibitors.
Validation
In vivo validation of target utilizing both industry standard and custom designed animal models for therapeutic validation.
Explore Our Therapeutic Indications
Chronic Pain
Targeting underlying inflammation driving chronic
inflammatory and neuropathic pain